156 related articles for article (PubMed ID: 12084892)
41. [Can sural nerve biopsy be used to orientate the treatment of chronic inflammatory demyelinating polyneuropathy?].
Andrade R; González I; Machado A; García A
Rev Neurol; 2001 Dec 1-15; 33(11):1005-9. PubMed ID: 11785024
[TBL] [Abstract][Full Text] [Related]
42. High-dose cyclophosphamide without stem cell rescue for refractory multifocal motor neuropathy.
Brannagan TH; Alaedini A; Gladstone DE
Muscle Nerve; 2006 Aug; 34(2):246-50. PubMed ID: 16502421
[TBL] [Abstract][Full Text] [Related]
43. Long-term effects of intravenous immunoglobulin in CIDP.
Vucic S; Black K; Baldassari LE; Tick Chong PS; Dawson KT; Cros D
Clin Neurophysiol; 2007 Sep; 118(9):1980-4. PubMed ID: 17604689
[TBL] [Abstract][Full Text] [Related]
44. Long term prognosis of chronic inflammatory demyelinating polyneuropathy: a five year follow up of 38 cases.
Kuwabara S; Misawa S; Mori M; Tamura N; Kubota M; Hattori T
J Neurol Neurosurg Psychiatry; 2006 Jan; 77(1):66-70. PubMed ID: 16361595
[TBL] [Abstract][Full Text] [Related]
45. The effect of IgG levels on the number of natural killer cells and their Fc receptors in chronic inflammatory demyelinating polyradiculoneuropathy.
Bohn AB; Nederby L; Harbo T; Skovbo A; Vorup-Jensen T; Krog J; Jakobsen J; Hokland ME
Eur J Neurol; 2011 Jun; 18(6):919-24. PubMed ID: 21219545
[TBL] [Abstract][Full Text] [Related]
46. Randomized controlled trial of IVIg in untreated chronic inflammatory demyelinating polyradiculoneuropathy.
Mendell JR; Barohn RJ; Freimer ML; Kissel JT; King W; Nagaraja HN; Rice R; Campbell WW; Donofrio PD; Jackson CE; Lewis RA; Shy M; Simpson DM; Parry GJ; Rivner MH; Thornton CA; Bromberg MB; Tandan R; Harati Y; Giuliani MJ;
Neurology; 2001 Feb; 56(4):445-9. PubMed ID: 11222785
[TBL] [Abstract][Full Text] [Related]
47. Subcutaneous immunoglobulin as first-line therapy in treatment-naive patients with chronic inflammatory demyelinating polyneuropathy: randomized controlled trial study.
Markvardsen LH; Sindrup SH; Christiansen I; Olsen NK; Jakobsen J; Andersen H;
Eur J Neurol; 2017 Feb; 24(2):412-418. PubMed ID: 28000311
[TBL] [Abstract][Full Text] [Related]
48. Acute motor response following a single IVIG treatment course in chronic inflammatory demyelinating polyneuropathy.
Harbo T; Andersen H; Jakobsen J
Muscle Nerve; 2009 Apr; 39(4):439-47. PubMed ID: 19229876
[TBL] [Abstract][Full Text] [Related]
49. Predicting response to treatment in chronic inflammatory demyelinating polyradiculoneuropathy.
Chan YC; Allen DC; Fialho D; Mills KR; Hughes RA
J Neurol Neurosurg Psychiatry; 2006 Jan; 77(1):114-6. PubMed ID: 16361609
[TBL] [Abstract][Full Text] [Related]
50. [A quadriplegic patient with chronic inflammatory demyelinating polyneuropathy (CIDP) who responded well to corticosteroids and intravenous immunoglobulin therapy].
Fukae J; Okuma Y; Noda K; Fujishima K; Goto K; Mizuno Y
No To Shinkei; 2001 Dec; 53(12):1115-8. PubMed ID: 11806118
[TBL] [Abstract][Full Text] [Related]
51. Randomised controlled trial of methotrexate for chronic inflammatory demyelinating polyradiculoneuropathy (RMC trial): a pilot, multicentre study.
RMC Trial Group
Lancet Neurol; 2009 Feb; 8(2):158-64. PubMed ID: 19136303
[TBL] [Abstract][Full Text] [Related]
52. Clinical and electrophysiologic correlates of IVIg responsiveness in CIDP.
Iijima M; Yamamoto M; Hirayama M; Tanaka F; Katsuno M; Mori K; Koike H; Hattori N; Arimura K; Nakagawa M; Yoshikawa H; Hayasaka K; Onodera O; Baba M; Yasuda H; Saito T; Nakazato M; Nakashima K; Kira J; Kaji R; Oka N; Sobue G
Neurology; 2005 Apr; 64(8):1471-5. PubMed ID: 15851750
[TBL] [Abstract][Full Text] [Related]
53. Therapy of CIDP and related immune-mediated neuropathies.
Koski CL
Neurology; 2002 Dec; 59(12 Suppl 6):S22-7. PubMed ID: 12499467
[TBL] [Abstract][Full Text] [Related]
54. Chronic inflammatory demyelinating polyradiculoneuropathy: update on clinical features, phenotypes and treatment options.
Eftimov F; van Schaik I
Curr Opin Neurol; 2013 Oct; 26(5):496-502. PubMed ID: 23852276
[TBL] [Abstract][Full Text] [Related]
55. Sustained remission of CIDP associated with Evans syndrome.
Knecht H; Baumberger M; Tobòn A; Steck A
Neurology; 2004 Aug; 63(4):730-2. PubMed ID: 15326255
[TBL] [Abstract][Full Text] [Related]
56. Chronic inflammatory demyelinating polyneuropathy presenting with features of GBS.
Mori K; Hattori N; Sugiura M; Koike H; Misu K; Ichimura M; Hirayama M; Sobue G
Neurology; 2002 Mar; 58(6):979-82. PubMed ID: 11914423
[TBL] [Abstract][Full Text] [Related]
57. Evolution and treatment of childhood chronic inflammatory polyneuropathy.
Rossignol E; D'Anjou G; Lapointe N; Haddad E; Vanasse M
Pediatr Neurol; 2007 Feb; 36(2):88-94. PubMed ID: 17275659
[TBL] [Abstract][Full Text] [Related]
58. Immunoablative high-dose cyclophosphamide without stem-cell rescue for refractory, severe autoimmune disease.
Brodsky RA; Petri M; Smith BD; Seifter EJ; Spivak JL; Styler M; Dang CV; Brodsky I; Jones RJ
Ann Intern Med; 1998 Dec; 129(12):1031-5. PubMed ID: 9867758
[TBL] [Abstract][Full Text] [Related]
59. Clinical Characteristics and Treatment Response of Chronic Inflammatory Demyelinating Polyradiculoneuropathy.
Suanprasert N; Hanchaiphiboolkul S
J Med Assoc Thai; 2017 Mar; 100(3):262-9. PubMed ID: 29911781
[TBL] [Abstract][Full Text] [Related]
60. Childhood chronic inflammatory demyelinating polyneuroradiculopathy--three cases and a review of the literature.
Riekhoff AG; Jadoul C; Mercelis R; Cras P; Ceulemans BP
Eur J Paediatr Neurol; 2012 Jul; 16(4):315-31. PubMed ID: 22225859
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
